Travere Therapeutics (TVTX) Capital Expenditures Growth (1y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 143.40% |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 2,633.33% |
| Dec 31, 2023 | -16.67% |
| Sep 30, 2023 | -23.08% |
| Jun 30, 2023 | -82.35% |
| Mar 31, 2023 | 380.92% |
| Dec 31, 2022 | -80.52% |
| Sep 30, 2022 | -96.28% |
| Jun 30, 2022 | -83.50% |
| Mar 31, 2022 | -97.09% |
| Dec 31, 2021 | 115.01% |
| Sep 30, 2021 | -85.51% |
| Jun 30, 2021 | -66.77% |
| Mar 31, 2021 | 2,061.06% |
| Dec 31, 2020 | -1,027.47% |
| Sep 30, 2020 | 808.68% |
| Jun 30, 2020 | 15,400.00% |
| Mar 31, 2020 | 994.74% |
| Dec 31, 2019 | 87.48% |
| Sep 30, 2019 | 110.32% |
| Jun 30, 2019 | -99.64% |
| Mar 31, 2019 | -51.28% |
| Dec 31, 2018 | -32.18% |
| Sep 30, 2018 | -66.93% |
| Jun 30, 2018 | 157.80% |
| Mar 31, 2018 | -95.35% |
| Dec 31, 2017 | -140.23% |
| Sep 30, 2017 | 929.73% |
| Mar 31, 2017 | 3,391.67% |
| Dec 31, 2016 | 10,615.38% |
| Sep 30, 2016 | 516.67% |
| Mar 31, 2016 | -4.00% |
| Dec 31, 2015 | -115.85% |
| Sep 30, 2015 | -96.18% |
| Jun 30, 2015 | -98.45% |
| Mar 31, 2015 | -84.95% |
| Dec 31, 2014 | -13.46% |
| Mar 31, 2014 | 2,328.30% |